-
Tecfidera Compared to Bafiertam in Phase 1 Study of GI Tolerability
The first healthy volunteer has enrolled in a single-site, randomized Phase 1 study of GI tolerabilty that compares oral Tecfidera to bioequivalent Bafiertam. Learn more about the study here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.